Hot Products
		
		
	| Catalog No. | Information | 
| CFN90510 | Columbianetin acetate Columbianetin may be helpful in regulating mast cell-mediated allergic inflammatory responses, the absorption of columbianetin acetate is a passive diffusion process without pH-dependent.  | 
						
| CFN90480 | Columbin  Columbin has anti-inflammation activity, it has chemopreventive ability against human colon cancer, it also can inhibit growth of culture forms of Trypanosoma brucei. Columbin inhibits PLA2 hydrolysis of ghost RBC in a dose-dependent fashion.  | 
						
| CFN91873 | Colupulone Colupulone is an inducer of hepatic cytochrome P-4503A .Colupulone can increase cytochrome P450IIB and P450IIIA steady-state mRNA levels. Colupulone also has antibacterial effects.  | 
						
| CFN91022 | Colutehydroquinone Colutehydroquinone and colutequinone are antifungal isoflavonoids from Colutea arborescens.  | 
						
| CFN98332 | Communic acid Communic acid has antibacterial activity, including against mycobacterial. trans-Communic acid has potential to be utilized as anti-wrinkling agents and cosmetic ingredients, as they suppress UVB-induced MMP-1 expression.  | 
						
| CFN91011 | Complanatoside Complanatoside C is a natural product from Astragali Semen.  | 
						
| CFN99525 | Complanatoside A Complanatoside A is a flavonol glycoside isolated from Astragalus complanatus, and currently it is used as a quality control index for A. complanatus in the 2010 edition of the Chinese Pharmacopoeia.  | 
						
| CFN80156 | Complanatoside B Reference standards.  | 
						
| CFN98868 | Conduritol A Conduritol A has a hypoglycemic effect, can have an effect on regulating the metabolism of blood lipid, free-radical scavenging, enhancing the antioxidant ability, potentiating immune function; it also can markedly prevent the diabetic rats from getting cataracts through the inhibition of lens aldose reductase.  | 
						
| CFN70405 | Conessine Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa, it shows antibacterial, antifeedant, and anti-malarial effects. Conessine treatment reduces dexamethasone-induced muscle atrophy by regulating MuRF1 and atrogin-1 expression  |